Meglutol

This classification denotes an anticholesteremic agent, enzyme inhibitor, hydroxymethylglutaryl-coa reductase inhibitor, and hypolipidemic agent with the molecular formula C6H10O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CLA99KCD53, chemically known as pentanedioic acid, 3-hydroxy-3-methyl- but generally known as meglutol, which bears US NIH Compound Identifier 1662. European Medicines Agency schedules Meglutol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08716MIG. World Health Organization schedules meglutol in its Anatomical Therapeutic Chemical (ATC) Classification. MEGLUTOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meglutol under HS 29181985 and SITC 51392. As of Q4 2014, MEGLUTOL remains the US FDA Preferred Term for this commodity. SMILES: OC(CC(=O)O)(CC(=O)O)C.